UlTRA DRIVE 300 (225MG BOLDENONE UNDECYLENATE AND 75MG METHANDRIOL DIPROPIONATE MIX)
METHANTRIOL BOLDENONE UNDECYCLENATE (DRIVE)
Active-Life: Boldenone-7-8 days/Methandriol 2-3 days
Drug Class: Mixture of anabolic/androgenic injectable steroids
Average reported dose: Men: 6-12 ml per week. Women 3-6 ml per week
Acne: Yes (due to Methandriol)
Water retention: Moderate
High blood pressure: depending on the dose
Liver Toxic: Low-Moderate (due to methandriol only)
DHT conversion: low
Decreases HPTA function: Yes, low to moderate (dose dependent)
This is a veterinary steroid manufactured in Australia and contains a mixture of two steroids: Boldenone Undecylenate (Equipoise/EQ) and Methandriol Dipropionate (MD). The combination produced a highly anabolic and androgenic mix that, thanks to Methandriol, had a high affinity for the receptors and caused some water retention for users. It was reported to be only mildly hepatotoxic and noted to moderately reduce HPTA function at higher doses. The combination was quite effective for building quality muscle mass while causing continuous gains in strength and weight. The resulting “lean tissue” quality was fairly well maintained after the cycle given the estrogenic effects of MD. This drug did not cause a rapid build-up of strength or mass like testosterone, but made for decent long-term progress. Men divided the injections weekly into 37 administrations with the best results of daily administration. This was probably due to methandriol’s relatively short active life. Like all products containing boldenone or methandriol, Pace would combine well with almost any anabolic product.
*Another similar veterinary AAS is Tribolin 75. This is a mixture of nandrolone decanoate (deca) and methandriol dipropionate in equal proportions, yielding 75 mg/ml
STANDARD TESTOSTERONE PROPIONATE
Active-Life: 2-3 days injectable / 4-6 hours orally Drug Class: Anabolic/Androgenic Steroids
Mean Reported Dosage: Tabs men 40-60 mg per day, injectable 100 mg every 2-3 days.
Water retention: high
High Blood Pressure: Yes
Liver Toxic: Injectable – Moderate/Oral – Yes due to higher dosage requirements
Remarks: Strong anabolic/strong androgenic/estrogenic activity
DHT conversion: unknown
Decreases HPTA function: Yes, significantly
MD is a highly anabolic/androgenic steroid with a unique reported quality of enhancing receptor affinity for/with other anabolic/androgenic compounds. It provided good muscle mass gains with good strength gains while causing high water retention. While the injection form was “said” to be easy on the liver, the tablet form is highly toxic to the liver due to its 17-alpha alkylated structure. Men normally injected 100 mg every second or third day, or took 300-600 mg in divided daily doses. Even after just 4 weeks of use, the orals can cause liver problems. The injectable form of MD is also available in combination with other steroids. These are the Australian veterinary medicines: Drive, Filibol Forte, Geldabol and Spectriol.
Something I liked about MD was its known ability to clean up androgen receptor sites. Often, individuals who had experienced so-called receptor burnout ended up using an MD product to discover new benefits. DNP does this too, but in a different way. When using site injection protocols, MD has been an excellent addition for me. Many have clearly reported improved growth of MD stacking with other AAS. It should be noted that the drug MD is similar in structure to a weak estrogen. This means that a higher dosage can lead to estrogenic side effects.
*Since both oral and injection forms of MD are c17-alkylated, it seems clear that both are potentially hepatotoxic, although the latter has a lower potential due to the dose administered compared